1352139-51-5 Usage
General Description
3,4-Dihydro Agomelatine is a chemical compound that is a derivative of agomelatine, an antidepressant and anxiolytic medication. It is a potent and selective agonist of the melatonin receptors MT1 and MT2, and a weak antagonist of the 5-HT2C receptors. 3,4-Dihydro Agomelatine has been shown to exhibit improved pharmacokinetic properties and a longer half-life compared to agomelatine, potentially enhancing its effectiveness and duration of action. Additionally, 3,4-Dihydro Agomelatine has demonstrated promising results in preclinical studies for the treatment of depression and anxiety disorders. Further research is needed to fully understand its therapeutic potential and safety profile in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 1352139-51-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,1,3 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1352139-51:
(9*1)+(8*3)+(7*5)+(6*2)+(5*1)+(4*3)+(3*9)+(2*5)+(1*1)=135
135 % 10 = 5
So 1352139-51-5 is a valid CAS Registry Number.
1352139-51-5Relevant articles and documents
PROCESSES FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)ETHYL]ACETAMIDE
-
, (2012/07/27)
The present invention relates to processes for the synthesis of N-[2-(7-methoxy-l - naphthethyl] acetamide, amorphous form of N-[2-(7-methoxy-l -naphthethyl] acetamide and pharmaceutical compositions thereof.
